Newborn drug testing practices in Iowa birthing hospitals

Area of Science:

• Neonatal care
• Public health policy
• Substance abuse research

Background:

• Federal law requires states to identify newborns exposed to maternal substance use.
• Lack of national guidelines leads to variable state and local newborn drug testing procedures.
• Iowa mandates reporting of maternal substance use during pregnancy as child abuse.

Purpose of the Study:

• To identify newborn drug testing policies and procedures in Iowa birthing hospitals.
• Assess current practices in response to maternal substance use during pregnancy.
• Evaluate reporting and support services for affected newborns and mothers.

Main Methods:

• Cross-sectional survey of all Iowa birthing hospitals.
• Electronic survey distributed to hospital representatives.
• Analysis of hospital policies on newborn drug testing.

Main Results:

• 97.1% of hospitals order newborn drug testing, typically for 25% or fewer newborns annually.
• Risk assessment tools are widely used (89.6%), but provider discretion is also common (62.7%).
• 86.6% report positive drug tests to child protective services; maternal notification (35.0%) and treatment referrals (45.5%) are suboptimal.

Conclusions:

• Most Iowa hospitals conduct newborn drug testing and report positive results.
• Risk assessment tools are the predominant method for guiding testing.
• Maternal notification and substance use disorder treatment referrals require significant improvement.